annual cash & cash equivalents:
$141.79M+$23.47M(+19.84%)Summary
- As of today (June 17, 2025), APGE annual cash & cash equivalents is $141.79 million, with the most recent change of +$23.47 million (+19.84%) on December 31, 2024.
- During the last 3 years, APGE annual cash & cash equivalents has fallen by -$10.10 million (-6.65%).
- APGE annual cash & cash equivalents is now -6.65% below its all-time high of $151.89 million, reached on December 31, 2022.
Performance
APGE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$106.92M-$34.87M(-24.59%)Summary
- As of today (June 17, 2025), APGE quarterly cash & cash equivalents is $106.92 million, with the most recent change of -$34.87 million (-24.59%) on March 31, 2025.
- Over the past year, APGE quarterly cash & cash equivalents has dropped by -$378.54 million (-77.98%).
- APGE quarterly cash & cash equivalents is now -77.98% below its all-time high of $485.46 million, reached on March 31, 2024.
Performance
APGE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
APGE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.8% | -78.0% |
| 3 y3 years | -6.7% | - |
| 5 y5 years | -6.7% | - |
APGE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.7% | +19.8% | -78.0% | at low |
| 5 y | 5-year | -6.7% | +19.8% | -78.0% | at low |
| alltime | all time | -6.7% | +19.8% | -78.0% | at low |
APGE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $106.92M(-24.6%) |
| Dec 2024 | $141.79M(+19.8%) | $141.79M(+19.4%) |
| Sep 2024 | - | $118.78M(-61.3%) |
| Jun 2024 | - | $307.30M(-36.7%) |
| Mar 2024 | - | $485.46M(+310.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $118.32M(-22.1%) | $118.32M(-37.2%) |
| Sep 2023 | - | $188.27M(+50.5%) |
| Jun 2023 | - | $125.07M(-11.5%) |
| Mar 2023 | - | $141.33M(-7.0%) |
| Dec 2022 | $151.89M | $151.89M |
FAQ
- What is Apogee Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Apogee Therapeutics?
- What is Apogee Therapeutics annual cash & cash equivalents year-on-year change?
- What is Apogee Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Apogee Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of APGE is $141.79M
What is the all time high annual cash & cash equivalents for Apogee Therapeutics?
Apogee Therapeutics all-time high annual cash & cash equivalents is $151.89M
What is Apogee Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, APGE annual cash & cash equivalents has changed by +$23.47M (+19.84%)
What is Apogee Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of APGE is $106.92M
What is the all time high quarterly cash & cash equivalents for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly cash & cash equivalents is $485.46M
What is Apogee Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, APGE quarterly cash & cash equivalents has changed by -$378.54M (-77.98%)